1. Durability of sustained virological response to glecaprevir/pibrentasvir and resistance development: A long‐term follow‐up study. (14th March 2022) Authors: Poordad, Fred; Felizarta, Franco; Yao, Betty B.; Overcash, J. Scott; Hassanein, Tarek; Agarwal, Kosh; Gane, Edward; Shaw, David; Waters, Michael; Krishnan, Preethi; Topp, Andrew; Burroughs, Margaret; Nevens, Frederik Journal: Liver international Issue: Volume 42:Number 6(2022) Page Start: 1278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study. Issue 1 (January 2021) Authors: Adams, David; Polydefkis, Michael; González-Duarte, Alejandra; Wixner, Jonas; Kristen, Arnt V; Schmidt, Hartmut H; Berk, John L; Losada López, Inés Asunción; Dispenzieri, Angela; Quan, Dianna; Conceição, Isabel M; Slama, Michel S; Gillmore, Julian D; Kyriakides, Theodoros; Ajroud-Driss, Senda; Wa... Journal: Lancet neurology Issue: Volume 20:Issue 1(2021) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study. Issue 1 (January 2021) Authors: Adams, David; Polydefkis, Michael; González-Duarte, Alejandra; Wixner, Jonas; Kristen, Arnt V; Schmidt, Hartmut H; Berk, John L; Losada López, Inés Asunción; Dispenzieri, Angela; Quan, Dianna; Conceição, Isabel M; Slama, Michel S; Gillmore, Julian D; Kyriakides, Theodoros; Ajroud-Driss, Senda; Wa... Journal: Lancet neurology Issue: Volume 20:Issue 1(2021) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Phase 1 Maximal Use Pharmacokinetic Study of Tirbanibulin Ointment 1% in Subjects With Actinic Keratosis. Issue 3 (16th November 2021) Authors: Yavel, Regina; Overcash, J. Scott; Cutler, David; Fang, Jane; Zhi, Jay Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 3(2022) Page Start: 397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia. Issue 25 (31st May 2019) Authors: Isturiz, Raul E.; Ramirez, Julio; Self, Wesley H.; Grijalva, Carlos G.; Counselman, Francis L.; Volturo, Gregory; Ostrosky-Zeichner, Luis; Peyrani, Paula; Wunderink, Richard G.; Sherwin, Robert; Overcash, J. Scott; Oliva, Senen Pena; File, Thomas; Wiemken, Timothy L.; McLaughlin, John M.; Pride, ... Journal: Vaccine Issue: Volume 37:Issue 25(2019) Page Start: 3352 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial. Issue 10 (October 2022) Authors: Ginde, Adit A.; Paredes, Roger; Murray, Thomas A.; Engen, Nicole; Grandits, Greg; Vekstein, Andrew; Ivey, Noel; Mourad, Ahmad; Sandkovsky, Uriel; Gottlieb, Robert L.; Berhe, Mezgebe; Jain, Mamta K.; Marines-Price, Rubria; Agbor Agbor, Barbine Tchamba; Mateu, Lourdes; España-Cueto, Sergio; Lladós,... Journal: Lancet Issue: Volume 10:Issue 10(2022) Page Start: 972 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗